Administration of Anti-CD19-chimeric-antigen-receptor-transduced T Cells From the Original Transplant Donor to Patients With Recurrent or Persistent B-cell Malignancies After Allogeneic Stem Cell Transplantation
Phase 1 Completed
85 enrolled
Clinical Study Aiming to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of a Single Administration of ZE50-0134 at 5 Dose Levels in Healthy Volunteers
Phase 1 Completed
104 enrolled
CLL-Frail
Phase 2 Completed
53 enrolled
CD19/CD22 Chimeric Antigen Receptor (CAR) T Cells in Children and Young Adults With Recurrent or Refractory CD19/CD22-expressing B Cell Malignancies
Phase 1 Completed
54 enrolled 24 charts
Safety Study of ABT-263 in Combination With Rituximab in Lymphoid Cancers
Phase 1 Completed
29 enrolled
ACALLO
Phase 2 Completed
29 enrolled
CLL2-BAAG
Phase 2 Completed
46 enrolled
CD19-CAR-T2 Cells for CD19 Positive B Cell Malignancies
Phase 2 Completed
77 enrolled
Dose-escalation Study of Oral Administration of S 55746 in Patients With Chronic Lymphocytic Leukaemia and B-Cell Non-Hodgkin Lymphoma
Phase 1 Completed
65 enrolled
UK-Haplo
Phase 2 Completed
77 enrolled
A Phase I Safety, PK and PD Study of KW-2478 in Patients With Multiple Myeloma, Chronic Lymphocytic Leukaemia or B-cell Non-Hodgkin's Lymphoma
Phase 1 Completed
27 enrolled
A Study of KW-2478 in Combination With Bortezomib in Subjects With Relapsed and/or Refractory Multiple Myeloma
Phase 1/2 Completed
95 enrolled 13 charts
A Study of Zilovertamab Vedotin (MK-2140) (VLS-101) in Participants With Hematologic Malignancies (MK-2140-001)
Phase 1 Completed
91 enrolled
Ofatumumab-based Induction Chemoimmunotherapy in Previously Untreated Patients With CLL/SLL
Phase 2 Completed
32 enrolled 16 charts
Study of the Prognostic Role of Gene Polymorphism in the Development of B-cell Leukemias and Lymphomas in Children of Kazakh Nationality
Completed
400 enrolled
CD19/CD20 Dual-CAR-T in B-cell Leukemia Patients
Phase 1 Completed
12 enrolled
CD19-targeting, 3rd Generation CAR T Cells for Refractory B Cells Malignancy
Phase 2 Completed
24 enrolled
A Phase Ib Study of ISF35 in Combination With Chemotherapy (FCR) in Subjects With Relapsed, Refractory, and/or 17p- CLL
Phase 1 Completed
13 enrolled
A Study of ABT-263 in Subjects With Relapsed or Refractory Lymphoid Malignancies
Phase 1/2 Completed
81 enrolled
BI-1206 and an Anti-CD20 Antibody in Patients With CD32b Positive B-cell Lymphoma or Leukaemia
Phase 1/2 Completed
14 enrolled 17 charts
Study to Evaluate the Safety and Tolerability of Tirabrutinib (ONO/GS-4059) Given as Monotherapy in Participants With Relapsed/Refractory NHL and CLL
Phase 1 Completed
90 enrolled 27 charts
A Study of the Kinetics of Lymphoid Cells in Patients With Monoclonal B-cell Lymphocytosis (MBL), Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL), Mantle Cell Lymphoma (MCL) and Healthy Volunteers
Completed
20 enrolled
Ofatumumab Added to Fludarabine-Cyclophosphamide vs Fludarabine-Cyclophosphamide Combination in Relapsed Subjects With Chronic Lymphocytic Leukemia
Phase 3 Completed
365 enrolled 28 charts
Sequential Regimen of Bendamustin-Debulking Followed by Ofatumumab and Ibrutinib in CLL Patients (CLL2-BIO)
Phase 2 Completed
66 enrolled
Safety and Tolerability Study of PCI-32765 in B Cell Lymphoma and Chronic Lymphocytic Leukemia
Phase 2 Completed
199 enrolled 14 charts
TLN-Registry
Completed
3,795 enrolled
Pedi CART19
Phase 1/2 Completed
73 enrolled 12 charts
Safety Study of CC-292 and Lenalidomide in Subjects With Chronic Lymphocytic Leukemia/ Small Lymphocytic Lymphoma
Phase 1 Completed
20 enrolled
A Dose Escalation Study of Lenalidomide in Relapsed or Refractory B-cell Chronic Lymphocytic Leukemia
Phase 1 Completed
52 enrolled
17p-CLL
Completed
41 enrolled
Study of MLN8237 in Participants With Advanced Hematological Malignancies
Phase 1 Completed
58 enrolled 52 charts
RETRO-idel
Completed
112 enrolled
CLEAR
Phase 2 Completed
71 enrolled
Stem Cell Transplantation for Patients With Cancers of the Blood
Phase 2 Completed
61 enrolled 6 charts
Improving Blood Stem Cell Collection and Transplant Procedures
Phase 1/2 Completed
43 enrolled
A Phase I Trial of DI-B4 in Patients With Advanced CD19 Positive Indolent B-cell Malignancies
Phase 1 Completed
28 enrolled
Lenalidomide Plus Bendamustine and Rituximab for Untreated CLL/SLL
Phase 1 Completed
34 enrolled
Ofatumumab Cardiac Repolarization (QTc) Study in Fludarabine-Refractory Chronic Lymphocytic Leukemia Subjects
Phase 1 Completed
12 enrolled
CD19-targeting 3rd Generation CAR T Cells for Refractory B Cell Malignancy - a Phase I/IIa Trial.
Phase 1/2 Completed
15 enrolled
Infusion of Allogeneic Umbilical Cord Blood-Derived Cluster of Differentiation Antigen 19 (CD19)-Specific T Cells
Phase 1 Completed
5 enrolled
A Phase I/II, a Single Arm, Open-label Study of Ofatumumab (GSK1841157) in Patients With Previously Treated Chronic Lymphocytic Leukemia
Phase 2 Completed
10 enrolled 35 charts
Pentostatin, and Rituximab With and Without Cyclophosphamide for Previously Untreated B-Chronic Lymphocytic Leukemia
Phase 2 Completed
28 enrolled
Ofatumumab Plus Bendamustine in Frontline and Relapsed Chronic Lymphocytic Leukaemia (CLL)
Phase 2 Completed
99 enrolled 27 charts
Safety Study of CC-292 and Rituximab in Subjects With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Phase 1 Completed
40 enrolled
A Phase I/II, Open-label Study of Ofatumumab Added to Chlorambucil in Previously Untreated Japanese Patients With Chronic Lymphocytic Leukemia
Phase 2 Completed
10 enrolled 52 charts
Study Evaluating the Tolerance and Biologic Activity of Oral Ciclopirox Olamine in Patients With Relapsed or Refractory Hematologic Malignancy
Phase 1 Completed
20 enrolled
Phase 1 Weekly Dosing of SCH 727965 in Patients With Advanced Cancer (Study P04629AM6)
Phase 1 Completed
123 enrolled
Phase 2 Fludarabine, Cytoxan and FCCAM <Alemtuzumab> in Untreated B-Cell Chronic Lymphocytic Leukemia
Phase 2 Completed
25 enrolled 7 charts
Safety and Tolerability Study of PCI-32765 Combined With Fludarabine/Cyclophosphamide/Rituximab (FCR) and Bendamustine/Rituximab (BR) in Chronic Lymphocytic Leukemia (CLL)
Phase 1 Completed
33 enrolled 13 charts
Phase IV Observational Study in Chronic Lymphocytic Leukemia
Completed
1 enrolled